The Gyeonggi Province Institute of Health and Environment is recruiting manufacturers and importers interested in signing a contract for outsourced quality testing of quasi-drugs in 2027. Applications are due by November 23.


Under the "Decree on Facility Standards for Manufacturers and Importers of Pharmaceuticals, etc.," manufacturers and importers of quasi-drugs must either maintain the facilities needed to conduct their own quality testing or outsource the testing to an organization authorized under the relevant regulations.


Since 2008, the Gyeonggi Province Institute of Health and Environment has supported quality testing for small quasi-drug companies in the province through annual quality testing outsourcing contracts.


Poster: Call for Companies Interested in 2027 Outsourced Quality Management Contracts for Quasi-Drugs

Poster: Call for Companies Interested in 2027 Outsourced Quality Management Contracts for Quasi-Drugs

View original image

Eligible applicants are manufacturers and importers of quasi-drugs headquartered in Gyeonggi Province. The quality testing support covers quasi-drugs closely related to residents' daily lives, including health masks and sanitary pads.


Details about the recruitment and required documents are available on the Gyeonggi Province website (gg.go.kr) and the Gyeonggi Province Institute of Health and Environment website (gg.go.kr/gg_health). Applications should be submitted by email to gghealth@gg.go.kr.



The institute plans to give priority to new and small companies and companies based in northern Gyeonggi Province, and announce the results on December 1.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing